IL1B and acute respiratory distress syndrome: In fact, most COVID-19 patients with severe illness have increased levels of IL-1β, which is associated with ARDS (64); therefore, inhibition of IL-1β can mitigate development of the cytokine storm that causes death in COVID-19 patients (65).